Dr. Baloh is the director of the Neuromuscular Division, working with Patrick D. Lyden, MD, chair of the Department of Neurology, and Clive Svendsen, PhD, director of Cedars-Sinai’s Regenerative Medicine Institute. When Lyden and Svendsen joined Cedars-Sinai in 2009, they identified ALS as a top clinical and research priority because of their collective experience and because there is no treatment for the fatal disease.

Baloh, a prolific research scientist who has published groundbreaking discoveries in genetics and molecular biology, is the principal investigator of multiple projects examining the molecular and cellular basis of neuromuscular disorders, primarily focused on ALS, but also on muscular dystrophies and inherited peripheral nerve and muscle disorders including Charcot-Marie-Tooth disease, one of the most common inherited neurological disorders, named for the three doctors who identified it in 1886.